Retrospective Cross-Sectional Analysis of Treatment Processes of Children Diagnosed with Obsessive Compulsive Disorder

Yıl 2020, Cilt: 1 Sayı: 1, 20 - 23, 22.09.2020

Halil Kara S. Burak Açıkel

https://doi.org/10.47482/acmr.2020.3

Öz

Background: Obsessive-compulsive disorder (OCD) is a severe, common and most often chronically debilitating disorder characterized by repetitive, ritualistic, and distressing thoughts, ideas, and behaviors. In this retrospective study, we have presented patients who have admitted to our clinic and was diagnosed with obsessive-compulsive disorder and their baseline and after-treatment symptom severity.

Methods: Participants who admitted to Aksaray University Faculty of Medicine Department of Child Adolescent Psychiatry were evaluated. Medical records were obtained by previous clinical evaluation and scaled scores for this retrospective study. The Schedule for Affective Disorders and Schizophrenia for School Age Children- Present and Lifetime Version, DSM-5 (K-SADS-PL) was applied to every patient at first session of treatment. Symptom severity of OCD was recorded according to Children’s Yale- Brown Obsessive-Compulsive Scale.

Results: 73 patients were included in the study. 49.3% was male, 50.7% was female. 52.1% of patients have one or more comorbid disorders. All patients were using at least one pharmacological agent. There was a significant difference between baseline and eight weeks after treatment CY-BOCS total scores (p<0.001). Conclusions: As a conclusion, pediatric OCD is a common and serious psychiatric disorder and SSRI medication is an effective choice. Compliance to treatment and regular follow-up is important for improvement.

Anahtar Kelimeler

Pediatric, Obsessive-Compulsive Disorder, Adolescent, Treatment.

Kaynakça

• 1.APA. The Diagnostic and Statistical Manual of Mental Disorders: DSM 5 [Internet]. 1. American Psychiatric Association; 2013. Available from: http://books.google.de/books?hl=en&lr=&id=_ V z z A g A A Q B A J & o i = f n d & p g = P T 2 & d q = d i a g n o s t i c + s y s t e m + o f + m e n t a l + d i s o r d e r s & o t s = oTWum7IZ1l&sig=2WJpMGqUijr9ShY7uaifRZwKslM
• 2. Janowitz D, Grabe HJ, Ruhrmann S, Ettelt S, Buhtz F, Hochrein A, et al. Early onset of obsessive-compulsive disorder and associated comorbidity. Depress Anxiety [Internet]. 2009;26(11):1012–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19691024
• 3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry [Internet]. 2005 Jun;62(6):593–602. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/15939837
• 4. Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev [Internet]. 2001 Feb;21(1):137–57. Available from: http://www.ncbi.nlm.nih. gov/pubmed/11148894
• 5. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA [Internet]. 2004 Oct 27;292(16):1969–76. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/15507582
• 6. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry [Internet]. 2012 Jan;51(1):98–113. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22176943
• 7. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry [Internet]. 2003 Nov;160(11):1919–28. Available from: http://www.ncbi.nlm.nih. gov/pubmed/14594734
• 8. Douglass HM, Moffitt TE, Dar R, McGee R, Silva P. Obsessivecompulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry [Internet]. 1995 Nov;34(11):1424–31. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/8543509
• 9. Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, et al. Fluoxetine in children and adolescents with OCD: a placebocontrolled trial. J Am Acad Child Adolesc Psychiatry [Internet]. 2002 Dec;41(12):1431–8. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/12447029
• 10. Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry [Internet]. 2001 Feb;40(2):222–9. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/11211371
• 11. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, et al. Sertraline in children and adolescents with obsessivecompulsive disorder: a multicenter randomized controlled trial. JAMA [Internet]. 1998 Nov 25;280(20):1752–6. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/9842950